Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 18;25(1):561.
doi: 10.1186/s12879-025-10964-w.

Genotyping and refractory risk factors of mycoplasma pneumoniae pneumonia in Suzhou, China

Affiliations

Genotyping and refractory risk factors of mycoplasma pneumoniae pneumonia in Suzhou, China

Wenjing Gu et al. BMC Infect Dis. .

Abstract

Objective: To investigate the genotyping and drug resistance of Mycoplasma pneumoniae (MP) epidemic strains in children and analyze the risk factors for refractory Mycoplasma pneumoniae pneumonia (RMPP).

Method: Nasopharyngeal aspirates (NPA) were collected from hospitalized children with MP infection from September to October 2023. Tracheoscopy was performed when necessary, and Bronchoalveolar Lavage Fluid (BALF) was collected. Polymerase Chain Reaction (PCR) capillary electrophoresis were used to detect respiratory pathogens, and a nested PCR based on the MP P1 gene monitored MP subtypes. The MP-23 S rRNA V region was amplified and sequenced. Clinical data and laboratory results were analyzed for RMPP risk factors.

Result: From 261 children diagnosed with Mycoplasma pneumoniae pneumonia (MPP), cough (100%) and fever (93.1%) were the most common symptoms. Moist rales (65.5%) were the prevalent pulmonary signs. Bronchoscopy was required in 44.4% of cases. Drug resistance genes were detected in 258 cases (98.9%). Genotyping showed 192 cases (73.56%) as type I and 69 cases (26.4%) as type II. Type I required more bronchoscope interventions (54.2%) compared to type II (17.4%, P < 0.001). Among the children, 92 (35.2%) were classified as RMPP. The RMPP group had longer hospitalization (9.14 ± 4.38 vs. 6.7 ± 1.81 days), higher fever ratio (100% vs. 89.9%), and longer febrile duration (8.72 ± 2.52 vs. 4.56 ± 2.50 days) (all P < 0.05). Higher rates of shortness of breath (7.6% vs. 1.2%) and decreased breath sounds (30.4% vs. 16.6%) were noted in the RMPP group (P < 0.05). Additionally, higher proportions of elevated CRP, ALT, AST, LDH, and D-D dimer were found in the RMPP group, along with a greater need for bronchoscopy (70.7% vs. 43.2%). Multivariate logistic regression identified total febrile duration, mucus plug formation, elevated AST, LDH, and D-D dimer as RMPP risk factors. Receiver operator characteristic (ROC) curve indicated that total febrile duration, LDH, and D-D dimer could serve as predictive markers for RMPP.

Conclusion: Type I predominated among MP strains in Suzhou, with a high prevalence of drug resistance. Type I infections were associated with a higher likelihood of requiring bronchoscopy. Prolonged fever, mucus plug formation, elevated AST, LDH, and D-D dimer were independent risk factors for RMPP, with total febrile duration, LDH, and D-D dimer serving as predictive markers.

Clinical trial number: Not applicable.

Keywords: Drug resistance genes; Genotyping; RMPP; Risk factors.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: This study performed in accordance with the Declaration of Helsinki. All the participants’ parents or guardians gave their written informed consent for participation in the study. The study was approved by the ethics committee of Children’s hospital of Soochow University [2018CS93]. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
ROC curve of RMPP

Similar articles

References

    1. Eaton MD, Meiklejohn G, van Herick W. Studies on the etiology of primary atypical pneumonia: A filterable agent transmissible to cotton rats, hamsters, and chick embryos. J Exp Med. 1944;79(6):649–68. - PMC - PubMed
    1. Kutty PK, et al. Mycoplasma pneumoniae among children hospitalized with Community-acquired pneumonia. Clin Infect Dis. 2019;68(1):5–12. - PMC - PubMed
    1. Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017;30(3):747–809. - PMC - PubMed
    1. Chang CH, et al. Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan. Pediatr Neonatol. 2021;62(5):536–42. - PubMed
    1. Xu YC, et al. Epidemiological characteristics and meteorological factors of childhood Mycoplasma pneumoniae pneumonia in Hangzhou. World J Pediatr. 2011;7(3):240–4. - PubMed

MeSH terms

Substances

LinkOut - more resources